patent for semaglutide Indian generics undercut Wegovy by as much as 87% after expiry Ozempic's patent problem: how Novo

Hypersensitivity Tesamorelin is contraindicated in patients with known hypersensitivity to tesamorelin and/or mannitol (an excipient)

Canada became only the second country in the world, and the first in the G7, to approve a generic version of semaglutide, after India in March 2026

For lab-driven weight loss programs, Marek Health is a higher-touch but more expensive alternative

We are lucky because we have an anatomy lab where we can do cadaveric studies first on the vascular anatomy

They can also suppress appetite even further, making it harder to meet protein and nutrient needs a challenge already posed by these medications